Literature DB >> 30972686

Prostate cancer detection using residual networks.

Helen Xu1, John S H Baxter2, Oguz Akin3, Diego Cantor-Rivera4.   

Abstract

PURPOSE: To automatically identify regions where prostate cancer is suspected on multi-parametric magnetic resonance images (mp-MRI).
METHODS: A residual network was implemented based on segmentations from an expert radiologist on T2-weighted, apparent diffusion coefficient map, and high b-value diffusion-weighted images. Mp-MRIs from 346 patients were used in this study.
RESULTS: The residual network achieved a hit or miss accuracy of 93% for lesion detection, with an average Jaccard score of 71% that compared the agreement between network and radiologist segmentations.
CONCLUSION: This paper demonstrated the ability for residual networks to learn features for prostate lesion segmentation.

Entities:  

Keywords:  Deep learning; Lesion segmentation; Multi-parametric MRI; Prostate cancer

Year:  2019        PMID: 30972686     DOI: 10.1007/s11548-019-01967-5

Source DB:  PubMed          Journal:  Int J Comput Assist Radiol Surg        ISSN: 1861-6410            Impact factor:   2.924


  4 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

2.  Computer-aided diagnosis of prostate cancer using a deep convolutional neural network from multiparametric MRI.

Authors:  Yang Song; Yu-Dong Zhang; Xu Yan; Hui Liu; Minxiong Zhou; Bingwen Hu; Guang Yang
Journal:  J Magn Reson Imaging       Date:  2018-04-16       Impact factor: 4.813

Review 3.  The contemporary concept of significant versus insignificant prostate cancer.

Authors:  Guillaume Ploussard; Jonathan I Epstein; Rodolfo Montironi; Peter R Carroll; Manfred Wirth; Marc-Oliver Grimm; Anders S Bjartell; Francesco Montorsi; Stephen J Freedland; Andreas Erbersdobler; Theodorus H van der Kwast
Journal:  Eur Urol       Date:  2011-05-17       Impact factor: 20.096

4.  Automated Detection of Clinically Significant Prostate Cancer in mp-MRI Images Based on an End-to-End Deep Neural Network.

Authors:  Zhiwei Wang; Chaoyue Liu; Danpeng Cheng; Liang Wang; Xin Yang; Kwang-Ting Cheng
Journal:  IEEE Trans Med Imaging       Date:  2018-05       Impact factor: 10.048

  4 in total
  5 in total

Review 1.  Applications of Artificial Intelligence to Prostate Multiparametric MRI (mpMRI): Current and Emerging Trends.

Authors:  Michelle D Bardis; Roozbeh Houshyar; Peter D Chang; Alexander Ushinsky; Justin Glavis-Bloom; Chantal Chahine; Thanh-Lan Bui; Mark Rupasinghe; Christopher G Filippi; Daniel S Chow
Journal:  Cancers (Basel)       Date:  2020-05-11       Impact factor: 6.639

2.  Deep learning for fully automatic detection, segmentation, and Gleason grade estimation of prostate cancer in multiparametric magnetic resonance images.

Authors:  Oscar J Pellicer-Valero; José L Marenco Jiménez; Victor Gonzalez-Perez; Juan Luis Casanova Ramón-Borja; Isabel Martín García; María Barrios Benito; Paula Pelechano Gómez; José Rubio-Briones; María José Rupérez; José D Martín-Guerrero
Journal:  Sci Rep       Date:  2022-02-22       Impact factor: 4.379

Review 3.  Current Value of Biparametric Prostate MRI with Machine-Learning or Deep-Learning in the Detection, Grading, and Characterization of Prostate Cancer: A Systematic Review.

Authors:  Henrik J Michaely; Giacomo Aringhieri; Dania Cioni; Emanuele Neri
Journal:  Diagnostics (Basel)       Date:  2022-03-24

Review 4.  State-of-the-Art Deep Learning Methods on Electrocardiogram Data: Systematic Review.

Authors:  Georgios Petmezas; Leandros Stefanopoulos; Vassilis Kilintzis; Andreas Tzavelis; John A Rogers; Aggelos K Katsaggelos; Nicos Maglaveras
Journal:  JMIR Med Inform       Date:  2022-08-15

Review 5.  Artificial Intelligence Based Algorithms for Prostate Cancer Classification and Detection on Magnetic Resonance Imaging: A Narrative Review.

Authors:  Jasper J Twilt; Kicky G van Leeuwen; Henkjan J Huisman; Jurgen J Fütterer; Maarten de Rooij
Journal:  Diagnostics (Basel)       Date:  2021-05-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.